Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2012
12/04/2012US8324225 Pyrrolopyrimidine compounds and their uses
12/04/2012US8324212 Compounds for the treatment of hepatitis C
12/04/2012CA2694401C Polycyclic compound
12/04/2012CA2687265C P70 s6 kinase inhibitors
12/04/2012CA2663511C Thiazole pyrazolopyrimidines as crf1 receptor antagonists
12/04/2012CA2618362C Hindered cyclic polyamines and their salts for acid gas scrubbing process
12/04/2012CA2548323C Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions
11/2012
11/29/2012WO2012162580A2 Anti-viral compounds
11/29/2012WO2012162269A2 Modular supramolecular approach for co-crystallization of donors and acceptors into ordered networks
11/29/2012WO2012161812A1 Tricyclic inhibitors of kinases
11/29/2012WO2012159565A1 6-(aryl-carboxamide) imidazo [1,2-a] pyrimidine and 6-(aryl carboxamide) [1,2,4] triazolo [4,3-a] pyrimidine as hedgehog pathway inhibitor and use thereof
11/29/2012WO2012159213A1 Compounds with oxime ester and/or acyl groups
11/29/2012US20120302747 Pyrrolotriazine kinase inhibitors
11/29/2012US20120302743 Long Wavelength Absorbing Porphyrin Photosensitizers for Dye-Sensitized Solar Cells
11/29/2012US20120302740 Vincristine immunoassay
11/29/2012US20120302596 Azaindoles having serotonin receptor affinity
11/29/2012US20120302586 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase
11/29/2012US20120302571 CRYSTALLINE FORMS OF (S)-1-(4-(5-CYCLOPROPYL-1H-PYRAZOL-3-YLAMINO)PYRROLO[1,2-f][1,2,4]TRIAZIN-2-YL)-N-(6-FLUOROPYRIDIN-3-YL)-2-METHYLPYRROLIDINE-2-CARBOXAMIDE
11/29/2012US20120302570 Heterocyclic oxime compounds
11/29/2012US20120302567 Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase
11/29/2012US20120302564 (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases
11/29/2012US20120302551 Thiolactams and uses thereof
11/29/2012US20120302550 Salts and polymorphs of 8-fluoro-2--1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
11/29/2012US20120302548 2-arylimidazole derivatives as pde10a enzyme inhibitors
11/29/2012US20120302540 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
11/29/2012US20120302524 1,3,4-oxadiazole-2-carboxamide compound
11/29/2012US20120302434 Six-membered n-heterocyclic carbene-based catalysts for asymmetric reactions
11/29/2012US20120301458 Cyclopropyl modulators of p2y12 receptor
11/29/2012US20120298976 N-Type Materials And Organic Electronic Devices
11/29/2012DE102006007309B4 Verbessertes Verfahren zur Herstellung von Temozolomid An improved process for the preparation of Temozolomide
11/29/2012CA2836817A1 Compounds with oxime ester and/or acyl groups
11/29/2012CA2827648A1 Tricyclic inhibitors of kinases
11/28/2012EP2527337A1 Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
11/28/2012EP2527325A1 Three-dimensional structure and manufacturing method for same
11/28/2012EP2527315A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/28/2012EP2526934A2 Inhibitors of bruton's tyrosine kinase
11/28/2012EP2526933A2 Inhibitors of bruton's tyrosine kinase
11/28/2012EP2526771A1 Inhibitors of bruton's tyrosine kinase
11/28/2012EP2526103A1 A process for the preparation of novel porphyrin derivatives and their use as pdt agents and fluorescence probes
11/28/2012EP2526102A1 Inhibitors of pi3 kinase
11/28/2012CN102803266A Purine compounds
11/28/2012CN102803265A Pyrrolopyrazine kinase inhibitors
11/28/2012CN102803264A 3-substituted-8-substituted-3h imidazo[5,1-d][1,2,3,5-tetrazin-4-one compounds and their use
11/28/2012CN102803261A Novel substituted bicyclic triazole derivatives as gamma secretase modulators
11/28/2012CN102803224A Novel azabicyclohexanes
11/28/2012CN102796511A Fluorescent probe for quantitatively detecting heparin, and synthesis method and application thereof
11/28/2012CN102796108A Natural chlorophyll iron-manganese salt and preparation method thereof
11/28/2012CN102796107A Method for synthesizing pyrrol[2,3-b]indole compounds
11/28/2012CN102796106A Pemetrexed quality control method, and preparation of pemetrexed impurity and salt thereof
11/28/2012CN102796105A 2, 5, 6, 7-tetrahydropyrrolo[3, 4-c] pyridazine-3-one, its derivative and synthesis method thereof
11/28/2012CN102796104A Method for synthesizing 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazol[4,3-a] pyrazine hydrochloride
11/28/2012CN102796103A 6-(aryl formyl) imidazo [1,2-a] pyrimidine and 6-(aryl formyl) [1,2,4] triazol [4,3-a] pyrimidine serving as Hedgehog inhibitors and application thereof
11/28/2012CN102796100A Substituted phenyl-(diazaspiro-N)-ketone derivative
11/28/2012CN102093366B Bicyclo-amino pyrazol compound and application of bicycle-amino pyrazol compound in resisting coxsackie virus
11/28/2012CN102002048B Water-soluble anionic bacteriochlorophyll derivatives and their uses
11/28/2012CN102002045B Pyrazolopyrimidinone derivatives as well as preparation method and application thereof
11/28/2012CN101903382B Heterocyclic antiviral compounds
11/28/2012CN101868458B Isoxazolo-pyridazine derivatives
11/28/2012CN101667626B Organic electroluminescent devices and metal complex compounds
11/28/2012CN101611037B Pyridyl-triazolopyrimidine derivative or its salt, pesticide containing it and its production process
11/28/2012CN101331134B Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
11/28/2012CN101318961B Fused heterocyclic compounds
11/27/2012US8319213 Aryl-aryl dendrimers
11/27/2012US8318928 Fused imidazole carboxamides as TRPV3 modulators
11/27/2012US8318794 Method of use of porphyrins in preparing a medicament for sonodynamic therapy and a method of sonodynamic therapy using porphyrins
11/27/2012US8318766 Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
11/27/2012US8318764 Macrocyclic inhibitors of JAK
11/27/2012US8318753 (-)-5-(3-Chlorophenyl)- alpha -(4-chlorophenyl)- alpha -(1-methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts; anticancer agent
11/27/2012US8318738 Reverse-turn mimetics and method relating thereto
11/27/2012US8318731 Pyrrolopyrimidines
11/27/2012US8318727 Polo-like kinase inhibitors
11/27/2012US8318467 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes
11/27/2012US8318450 Optically-detectable enzyme substrates and their method of use
11/27/2012CA2706571C 5-anilinoimidazopyridines and methods of use
11/27/2012CA2695742C Bicyclic amides for enhancing glutamatergic synaptic responses
11/27/2012CA2569364C Photoelectric conversion devices
11/27/2012CA2569016C Fused heterocyclic compound
11/27/2012CA2487805C Peptide deformylase inhibitors
11/27/2012CA2449830C New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
11/22/2012WO2012158811A2 Purine monophosphate prodrugs for treatment of viral infections
11/22/2012WO2012158810A1 Tyrosine kinase inhibitors
11/22/2012WO2012158795A1 Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
11/22/2012WO2012158785A1 Azaindole derivatives as tyrosine kinase inhibitors
11/22/2012WO2012158764A1 Tyrosine kinase inhibitors
11/22/2012WO2012158658A1 Fused bicyclic kinase inhibitors
11/22/2012WO2012158413A2 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012WO2012157631A1 Aliphatic amine-coordinated cerium complex and element comprising aliphatic amine-coordinated cerium complex
11/22/2012WO2012156888A1 Manufacturing process for sitagliptin from l-aspartic acid
11/22/2012WO2012156367A1 Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
11/22/2012WO2012156339A1 New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
11/22/2012WO2012142237A8 Fused imidazole derivatives useful as ido inhibitors
11/22/2012WO2012100229A3 Compositions and methods for cardiovascular disease
11/22/2012US20120296089 Inhibitors of bruton's tyrosine kinase
11/22/2012US20120296083 Three-dimensional structure and method of producing the same
11/22/2012US20120295946 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof
11/22/2012US20120295934 New Hexahydrocyclopentapyrrolone, Hexahydropyrrolopyrrolone, Octahydropyrrolopyridinone and Octahydropyridinone Compounds
11/22/2012US20120295925 Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
11/22/2012US20120295916 Orodispersible tablet containing compacted sildenafil base
11/22/2012US20120295913 Bicyclic pyrazole compounds as allosteric modulators of mglur5 receptors
11/22/2012US20120295903 Flavin derivatives
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 573